Elutia director granted 106K stock options
ELUTIA INC. director David Colpman received a grant of stock options covering 106,393 shares of Class A Common Stock at an exercise price of $0.96 per share.
Rhea-AI Filing Summary
ELUTIA INC. director David Colpman received a grant of stock options covering 106,393 shares of Class A Common Stock at an exercise price of $0.96 per share. The grant is compensation, not an open-market trade, and was awarded at no cost to him.
These options vest and become exercisable on the earlier of the day immediately preceding Elutia’s first annual meeting following the grant date or the first anniversary of the grant date, provided he continues serving on the board through the vesting date. The options expire on June 11, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 106,393 | $0.00 | $0.00 |
Footnotes (1)
- F1. This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
Class A Common Stock financial
Non-Employee Director Compensation Program financial
vests and becomes exercisable financial
FAQ
What did Elutia (ELUT) director David Colpman report on this Form 4?
What is the exercise price of David Colpman’s Elutia (ELUT) stock options?
When do David Colpman’s Elutia (ELUT) stock options vest?
When do the Elutia (ELUT) stock options granted to Colpman expire?
Is Colpman’s Elutia (ELUT) Form 4 transaction a stock purchase or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.